These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach. Rajeev M; Ratan C; Krishnan K; Vijayan M Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042 [TBL] [Abstract][Full Text] [Related]
23. Hutchinson-Gilford progeria syndrome as a model for vascular aging. Brassard JA; Fekete N; Garnier A; Hoesli CA Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290 [TBL] [Abstract][Full Text] [Related]
25. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells. Atchison L; Zhang H; Cao K; Truskey GA Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655 [TBL] [Abstract][Full Text] [Related]
26. Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway. Kinoshita D; Nagasawa A; Shimizu I; Ito TK; Yoshida Y; Tsuchida M; Iwama A; Hayano T; Minamino T Oncotarget; 2017 May; 8(21):34045-34056. PubMed ID: 28423660 [TBL] [Abstract][Full Text] [Related]
27. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Koblan LW; Erdos MR; Wilson C; Cabral WA; Levy JM; Xiong ZM; Tavarez UL; Davison LM; Gete YG; Mao X; Newby GA; Doherty SP; Narisu N; Sheng Q; Krilow C; Lin CY; Gordon LB; Cao K; Collins FS; Brown JD; Liu DR Nature; 2021 Jan; 589(7843):608-614. PubMed ID: 33408413 [TBL] [Abstract][Full Text] [Related]
28. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome. Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552 [TBL] [Abstract][Full Text] [Related]
29. Ghrelin delays premature aging in Hutchinson-Gilford progeria syndrome. Ferreira-Marques M; Carvalho A; Franco AC; Leal A; Botelho M; Carmo-Silva S; Águas R; Cortes L; Lucas V; Real AC; López-Otín C; Nissan X; de Almeida LP; Cavadas C; Aveleira CA Aging Cell; 2023 Dec; 22(12):e13983. PubMed ID: 37858983 [TBL] [Abstract][Full Text] [Related]
30. Nuclear membrane ruptures underlie the vascular pathology in a mouse model of Hutchinson-Gilford progeria syndrome. Kim PH; Chen NY; Heizer PJ; Tu Y; Weston TA; Fong JL; Gill NK; Rowat AC; Young SG; Fong LG JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423791 [TBL] [Abstract][Full Text] [Related]
32. Hutchinson-Gilford Progeria Syndrome: Cellular Mechanisms and Therapeutic Perspectives. Cisneros B; García-Aguirre I; De Ita M; Arrieta-Cruz I; Rosas-Vargas H Arch Med Res; 2023 Jul; 54(5):102837. PubMed ID: 37390702 [TBL] [Abstract][Full Text] [Related]
33. Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome. Kang SM; Seo S; Song EJ; Kweon O; Jo AH; Park S; Woo TG; Kim BH; Oh GT; Park BJ Cells; 2023 Apr; 12(9):. PubMed ID: 37174632 [TBL] [Abstract][Full Text] [Related]